Recombinant BRD7 anticorps (AA 150-200)
Aperçu rapide pour Recombinant BRD7 anticorps (AA 150-200) (ABIN7449350)
Antigène
Voir toutes BRD7 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 150-200
-
Fonction
- Rabbit anti-BRD7 Recombinant Monoclonal Antibody [BLR220K]
-
Immunogène
- between AA 150 and 200
-
Isotype
- IgG
-
-
-
-
Indications d'application
- 01:01,00
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 500 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.1 % BSA and 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Autre désignation
- BRD7
-
Sujet
- Background: Bromodomain-containing protein 7 was identified in a two-hybrid screen as an interactor of interferon regulatory factor-2 (IRF-2) and called CELTIX1. BRD7 was also identified as a binding partner of disheveled-1 (Dvl-1) and found to play a role in Wnt signaling and the regulation of glycogen synthase kinase 3-beta activity. Recently, BRD7 was identified as a subunit of the polybromo-associated BRG1-associated factor (PBAF) complex and shown to be required for the modulation of transcription in embryonic stem cells.
-
ID gène
- 29117
-
NCBI Accession
- NP_037395
-
UniProt
- Q9NPI1
Antigène
-